This article examines the evidence, mechanisms, symptoms, and management strategies for gallbladder issues related to GLP-1 therapy
Specific recommendations are provided to minimize nausea, vomiting, diarrhea, and constipation associated with GLP-1 therapies, as well as to prevent and manage complications such as, cholelithiasis and gastroesophageal reflux disease
Hypoglycemic drugs are beneficial to kidney function by decreasing albumin urine and delaying the progression of kidney fibrosis in DKD[3]
By reducing excessive inflammation, it supports a balanced immune system and prevents the negative impacts of prolonged inflammatory states on overall health
Tirzepatide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to tirzepatide during pregnancy